Large-scale testing (Phase 3)Study completedNCT01358760What this trial is testingDehydroepiandrosterone (DHEA) Against Vaginal AtrophyWho this might be right forVaginal Atrophy EndoCeutics Inc. 450
Testing effectiveness (Phase 2)WithdrawnNCT04159493What this trial is testingControlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal AtrophyWho this might be right forVaginal Atrophy Aspen USA Inc
Not applicableActive Not RecruitingNCT04081805What this trial is testingLASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)Who this might be right forVaginal AtrophyVulva; AtrophyBreast Cancer Federal University of São Paulo 195
Large-scale testing (Phase 3)UnknownNCT03782480What this trial is testingExamining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal AtrophyWho this might be right forMenopauseGenitourinary Syndrome of MenopauseVulvovaginal Atrophy+2 more Center for Vulvovaginal Disorders 40
Large-scale testing (Phase 3)Study completedNCT02668796What this trial is testingTo Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.Who this might be right forVulvar and Vaginal Atrophy Glenmark Pharmaceuticals Ltd. India 522
Large-scale testing (Phase 3)Study completedNCT02770365What this trial is testingComparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal AtrophyWho this might be right forAtrophy Padagis LLC 695
Large-scale testing (Phase 3)Study completedNCT01779947What this trial is testingStudy to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to PlaceboWho this might be right forAtrophic Vaginitis Due to Menopause Amneal Pharmaceuticals, LLC 519
Post-approval studies (Phase 4)Study completedNCT04705883What this trial is testingVaginal Prasterone In Vaginal Atrophy In Breast Cancer SurvivorsWho this might be right forVulvar AtrophyBreast CancerGenitourinary Syndrome of Menopause Hospital Clinic of Barcelona 10
Testing effectiveness (Phase 2)Study completedNCT02449902What this trial is testingTXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal AtrophyWho this might be right forMenopauseVulvovaginal AtrophyPainful Intercourse+1 more TherapeuticsMD 50
Large-scale testing (Phase 3)Study completedNCT01256684What this trial is testingDHEA Against Vaginal Atrophy - 3-Month Efficacy StudyWho this might be right forVaginal Atrophy EndoCeutics Inc. 255
Large-scale testing (Phase 3)Study completedNCT00276094What this trial is testingA Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal WomenWho this might be right forAtrophyVaginal Diseases Shionogi 826
Large-scale testing (Phase 3)Study completedNCT03332303What this trial is testingStudy to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal AtrophyWho this might be right forVulvar and Vaginal Atrophy Prasco LLC 540
Large-scale testing (Phase 3)UnknownNCT06514586What this trial is testingThe Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal AtrophyWho this might be right forVaginal AtrophyGenitourinary Syndrome of MenopauseVulvar Atrophy Oxagon 244
Large-scale testing (Phase 3)Study completedNCT00727129What this trial is testingStudy to Evaluate Divigel for the Treatment of Postmenoupausal SymptomsWho this might be right forPostmenopausal Symptoms Upsher-Smith Laboratories 495
Testing effectiveness (Phase 2)Study completedNCT05378269What this trial is testingStudy of Intravaginal Tamoxifen in PostMenopausal Women With VVAWho this might be right forVulvar Atrophy Daré Bioscience, Inc. 17
Large-scale testing (Phase 3)Study completedNCT01585558What this trial is testingLong-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact UterusWho this might be right forAtrophyVaginal Diseases Shionogi 180
Not applicableStudy completedNCT03063684What this trial is testingFractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen SclerosusWho this might be right forVaginal AtrophyLichen Sclerosus Hadassah Medical Organization 16
Post-approval studies (Phase 4)Study completedNCT00160173What this trial is testingEfficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal AtrophyWho this might be right forPostmenopausal Symptoms ASCEND Therapeutics 221
Large-scale testing (Phase 3)Study completedNCT01586364What this trial is testingLong-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a UterusWho this might be right forAtrophyVaginal Diseases Shionogi 301
Large-scale testing (Phase 3)Study completedNCT00566982What this trial is testingA Clinical Study to Evaluate the Safety of OspemifeneWho this might be right forAtrophyVaginal Diseases Shionogi 426